XML 26 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements
9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value MeasurementsThe following table presents information about the Company's assets and liabilities measured and reported in the financial statements at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques utilized to determine such fair value.
September 30, 2022
Level 1Level 2Level 3Balance
Assets:
Money market funds$16,682$$$16,682
Total assets$16,682$$$16,682
Liabilities:
Common stock warrant liability - public warrants$1,435 $— $— $1,435 
Common stock warrant liability - private placement warrants— 824 — 824 
Total liabilities$1,435$824$$2,259
December 31, 2021
Level 1Level 2Level 3Balance
Assets:
Money market funds$94,973 $— $— $94,973 
Total assets$94,973$$$94,973
Liabilities:
Common stock warrant liability - public warrants$4,486 $— $— $4,486 
Common stock warrant liability - private placement warrants2,5752,575
Total liabilities$4,486$2,575$$7,061
Money market funds are included within Level 1 of the fair value hierarchy because they are valued using quoted market prices. The common stock warrant liability for the public warrants as of September 30, 2022 is also included within Level 1 of the fair value hierarchy because they are valued using quoted market prices. The private placement warrants are included within Level 2 of the fair value hierarchy as the Company determined that the private placement warrants are economically equivalent to the public warrants and estimated the fair value of the private placement warrants based on the quoted market price of the public warrants. See Part II, Item 8 "Financial Statements and Supplementary Data - Note 10 to the Consolidated Financial Statements - Common Stock Warrants and Earnout Shares" in the Form 10-K for more information on the common stock warrants.

There were no transfers between Level 1 and Level 2 in the periods reported. There were no transfers into or out of Level 3 in the periods reported.